January 23, 2018 / 11:02 PM / 4 months ago

BRIEF-Array Biopharma Says Its partner Seeks Withdrawal of Marketing Authorization Applications For Binimetinib Monotherapy in EU, Switzerland And Australia

Jan 23 (Reuters) - Array Biopharma Inc:

* ARRAY BIOPHARMA SAYS PIERRE FABRE MEDICAMENT, REQUESTED THAT MARKETING AUTHORIZATION APPLICATIONS FOR BINIMETINIB MONOTHERAPY BE WITHDRAWN

* ARRAY BIOPHARMA - WITHDRAWAL OF MAA APPLICATIONS FOR BINIMETINIB MONOTHERAPY IN NRAS-MUTANT MELANOMA REQUESTED IN EU, SWITZERLAND AND AUSTRALIA

* ARRAY BIOPHARMA - PIERRE FABRE MEDICAMENT IS ARRAY'S COLLABORATION PARTNER Source text: (bit.ly/2DGm2Ug) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below